| Predicate |
Object |
| contentType |
Comment|Journal Article |
| issn |
1056-8751
1539-8560 |
| issueIdentifier |
3 |
| pageRange |
68- |
| publicationName |
ACP Journal Club |
| startingPage |
68 |
| bibliographicCitation |
Gould MK. Fondaparinux was not inferior to unfractionated heparin for symptomatic pulmonary embolism. ACP Journal Club. 2004 May 01;140(3):68. doi: 10.7326/acpjc-2004-140-3-068. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffb4919f02cb08a3c25229cc64f12060 |
| date |
2004-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.7326/acpjc-2004-140-3-068
https://pubmed.ncbi.nlm.nih.gov/15122831 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8544
https://portal.issn.org/resource/ISSN/1539-8560
https://portal.issn.org/resource/ISSN/1056-8751 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Fondaparinux was not inferior to unfractionated heparin for symptomatic pulmonary embolism |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9022 |